Clinical Trial Update: Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia [Phase 2]

View source ↗

Summary

A Phase 2 randomized study comparing EDP-420 to a comparator antibiotic for community-acquired pneumonia, sponsored by Enanta Pharmaceuticals; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• EDP-420

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: Community Acquired Pneumonia | Phase 2 | Status: UNKNOWN